In President Joe Biden’s brazen attempts to erase virtually all of former President Donald Trump’s legacy, Biden has halted an order passed by his predecessor that would have significantly lowered prescription drug price, including life-saving insulin and epinephrine. His Department of Health and Human Services will reevaluate the law in March, though President Biden has given no indication it will be reinstated.
The law requires all community health centers to pass on their discount savings on insulin and epinephrine to patients, lowering prices for patients. Centers that refused would not receive federal grants.
However, as apart of Biden’s administration’s intent to rid America of Trump, any orders on health passed by Trump will also be suspended if they have concerns over “fact, law, or policy.” The administration is awaiting at least a dozen more lawsuits over orders to lower drug prices that could impact numerous Trump-era orders.
In a federal register post, the Department of Health and Human Services explained the delay of the order “is necessary to give Department officials the opportunity for further review and consideration of new regulations.”
Trump announced the new regulation in July, proudly asserting, “the first order will require federal community health centers to pass the giant discounts they received from drug companies on insulin and EpiPens directly to their patients. You know insulin became so expensive people weren’t able to use it. They desperately needed it,” during the signing ceremony.
The Trump administraion prioritized ending “a shadowy system of kickbacks by middlemen that lurks behind the high out-of-pocket costs many Americans face at the pharmacy counter,” as HHS announced last July, while the Biden administration seems to be taking a potentially more deadly route on healthcare.